Business
RAC) share price jumps 13% on study breakthrough
Image source: Getty Images
Shares in Australian pharmaceutical company Race Oncology Ltd (ASX: RAC) jumped higher today and finished 13% in the green.
Investors bid up the Race Oncology share price following study readouts for its lead drug candidate, Zantrene, in a heart safety research…
Continue Reading
-
General14 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News22 hours agoStudents say new facility would be better in rural areas of Queensland
-
General16 hours ago‘We are here for you’: PM to bring help to flood zones
-
Business11 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…